Physician profile
Paul Guillard
NPI 1174516769
$374.64
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.44 · 2022: $92.75 · 2023: $169 · 2024: $33.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.42 | 2022-2024 | |
| Glaxosmithkline, LLC. | $71.22 | 2022-2023 | Shingrix |
| Novo Nordisk INC | $64.40 | 2021-2023 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $31.53 | 2023 | Eliquis |
| Apria Healthcare LLC | $18.34 | 2021 | |
| Lilly USA, LLC | $17.44 | 2023 | Jardiance, Emgality |
| Eisai INC. | $15.56 | 2021 | |
| Pfizer INC. | $14.74 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Guillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.